A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment
K. Reich, M. Augustin*, D. Thaçi, A. Pinter, A. Leutz, C. Henneges, E. Schneider, A. Schacht, M. Dossenbach, U. Mrowietz
*Korrespondierende/r Autor/-in für diese Arbeit
39
Link öffnet neuen Tab
Zitate (Scopus)